Correlation Between Hyaluronic Acid, Hyaluronic Acid Synthase And Human Renal Clear Cell Carcinoma

被引:6
作者
Cai, Jian-liang [1 ]
Li, Ming [2 ]
Na, Yan-qun [1 ]
机构
[1] Peking Univ, Shougang Hosp, Wu Jieping Urol Ctr, Beijing 100144, Peoples R China
[2] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Urol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
关键词
Renal clear cell carcinoma; Hyaluronic acid; Hyaluronic acid synthase; Gene; EXPRESSION; KIDNEY; CD44; SIZE;
D O I
10.1007/s11670-011-0059-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To study the correlation between hyaluronic acid (HA), hyaluronic acid synthase (HAS) and human renal clear cell carcinoma (RCCC). Methods: The expression of three HAS isoforms' gene and HA in 93 RCCC tissues, 27 nephridial tissues by the side of RCCC from two hospitals were measured with Real-Time RT-PCR. Western Blot and immunohistochemical methods and analyzed. Results: All RCCC and adjacent normal tissues expressed three HASs' mRNA & protein; at the mRNA level, both RCCC and adjacent normal tissues, expressed more HAS3 than HAS1 or HAS2, their differences were statistically significant (all P values <0.05); but, at the protein level, all HAS isoforms presented the equivalent expression. Compared with the adjacent non-neoplastic kidney tissues, the expression of all HAS isoforms' mRNA in RCCC tissues were increased evidently and their differences were significant (all P values <0.0001); but at the protein level, only the expression of HAS3 increased evidently (P=0.022). In all adjacent normal tissues, more than 80% renal tubular cells strongly expressed HA, however, only the minority RCCC cases (16/93) presented weakly positive HA staining in few cancer nests (5%-30%), the difference were significant (P<0.0001). In RCCC tissues subgrouped according to clinical stage, pathological grade, lymphatic metastasis or not and distant metastasis or not, the HASs' mRNA & protein differential expression all had no statistical significance (all P values >0.05). Conclusion: Different from other malignancy, HA and HASs (except for HAS3) may not play important roles in the biological progress of human RCCC.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 16 条
[1]   Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells [J].
Asselman, M ;
Verhulst, A ;
Van Ballegooijen, ES ;
Bangma, CH ;
Verkoelen, CF ;
De Broe, ME .
KIDNEY INTERNATIONAL, 2005, 68 (01) :71-83
[2]   The distribution of renal hyaluronan and the expression of hyaluronan synthases during water deprivation in the Spinifex hopping mouse, Notomys alexis [J].
Bartolo, Ray C. ;
Donald, John A. .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2007, 148 (04) :853-860
[3]  
Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283
[4]  
[蔡建良 Cai Jianliang], 2004, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V21, P1226
[5]  
CAI JL, 2008, J CLIN UROL, V23, P348
[6]  
Declèves AE, 2006, INT J MOL MED, V18, P83
[7]   Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties [J].
Itano, N ;
Sawai, T ;
Yoshida, M ;
Lenas, P ;
Yamada, Y ;
Imagawa, M ;
Shinomura, T ;
Hamaguchi, M ;
Yoshida, Y ;
Ohnuki, Y ;
Miyauchi, S ;
Spicer, AP ;
McDonald, JA ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :25085-25092
[8]   Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis - Pivotal role of a hyaluronan-rich tumor microenvironment [J].
Koyama, Hiroshi ;
Kobayashi, Nobutaka ;
Harada, Michihiko ;
Takeoka, Michiko ;
Kawai, Yoshiko ;
Sano, Kenji ;
Fujimori, Minoru ;
Amano, Jun ;
Ohhashi, Toshio ;
Kannagi, Reiji ;
Kimata, Koji ;
Taniguchi, Shun'ichiro ;
Itano, Naoki .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (01) :179-193
[9]   Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes [J].
Kuang, Dong-Ming ;
Wu, Yan ;
Chen, Nini ;
Cheng, Jiasen ;
Zhuang, Shi-Mei ;
Zheng, Limin .
BLOOD, 2007, 110 (02) :587-595
[10]   Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells [J].
Nakata, S ;
Yoshida, T ;
Horinaka, M ;
Shiraishi, T ;
Wakada, M ;
Sakai, T .
ONCOGENE, 2004, 23 (37) :6261-6271